Effect of Duodenal–Jejunal Bypass Surgery on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1930-739x|23|10|1973-1979

ISSN： 1930-7381

Source： OBESITY, Vol.23, Iss.10, 2015-10, pp. : 1973-1979

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Duodenal–Jejunal Bypass Surgery on Glycemic Control in Type 2 Diabetes: A Randomized Controlled Trial

By  

OBESITY, Vol. 1930-7381, Iss. 10, 2015-10 ,pp. : 1973-1979

John Wiley & Sons Inc

Access to resources Recommend Favorite

LX4211, a Dual SGLT1/SGLT2 Inhibitor, Improved Glycemic Control in Patients With Type 2 Diabetes in a Randomized, Placebo‐Controlled Trial

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 158-169

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Acarbose on Glycemic Variability in Patients with Poorly Controlled Type 2 Diabetes Mellitus Receiving Stable Background Therapy: A Placebo‐Controlled Trial

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 11, 2015-11 ,pp. : 983-990

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of duodenal‐jejunal bypass

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 308-315

John Wiley & Sons Inc

Access to resources Recommend Favorite

Duodenal‐jejunal bypass surgery induces hepatic lipidomic alterations associated with ameliorated hepatic steatosis in mice

By  

OBESITY, Vol. 24, Iss. 9, 2016-09 ,pp. : 1938-1945

John Wiley & Sons Inc

Access to resources Recommend Favorite